Subset analysis of the safety and efficacy of nivolumab in elderly patients with metastatic melanoma

by Freeman, Morganna, Weber, Jeffrey
Published 2015

Folding and Stabilization of Native-Sequence-Reversed Proteins

by Zhang, Yuanzhao, Weber, Jeffrey K, Zhou, Ruhong
Published 2016

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant

by Koh, Yi T, Higgins, Sean A, Weber, Jeffrey S, Kast, W Martin
Published 2006

Markov State Models Provide Insights into Dynamic Modulation of Protein Function

by Shukla, Diwakar, Hernández, Carlos X., Weber, Jeffrey K., Pande, Vijay S.
Published 2015

Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic Melanoma

by Critchley-Thorne, Rebecca J, Yan, Ning, Nacu, Serban, Weber, Jeffrey, Holmes, Susan P, Lee, Peter P
Published 2007

Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)

by Bartell, Heddy, Wolchok, Jedd, Hodi, F Stephen, Liu, Helen, Wojtaszek, Cynthia, Weber, Jeffrey
Published 2015

Surface Curvature Relation to Protein Adsorption for Carbon-based Nanomaterials

by Gu, Zonglin, Yang, Zaixing, Chong, Yu, Ge, Cuicui, Weber, Jeffrey K., Bell, David R., Zhou, Ruhong
Published 2015

Cytotoxic T lymphocyte responses against melanocytes and melanoma

by Chang, Gwendolen Y, Kohrt, Holbrook E, Stuge, Tor B, Schwartz, Erich J, Weber, Jeffrey S, Lee, Peter P
Published 2011

Marked Differences in Human Melanoma Antigen-Specific T Cell Responsiveness after Vaccination Using a Functional Microarray

by Chen, Daniel S, Soen, Yoav, Stuge, Tor B, Lee, Peter P, Weber, Jeffrey S, Brown, Patrick O, Davis, Mark M
Published 2005

Diversity and Recognition Efficiency of T Cell Responses to Cancer

by Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, Lee, Peter P
Published 2004

Biomarkers on melanoma patient T Cells associated with ipilimumab treatment

by Wang, Wenshi, Yu, Daohai, Sarnaik, Amod A, Yu, Bin, Hall, Maclean, Morelli, Dawn, Zhang, Yonghong, Zhao, Xiuhua, Weber, Jeffrey S
Published 2012

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma

by Brohl, Andrew S., Khushalani, Nikhil I., Eroglu, Zeynep, Markowitz, Joseph, Thapa, Ram, Chen, Y. Ann, Kudchadkar, Ragini, Weber, Jeffrey S.
Published 2016

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

by Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Published 2012

Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy

by Chacon, Jessica Ann, Wu, Richard C., Sukhumalchandra, Pariya, Molldrem, Jeffrey J., Sarnaik, Amod, Pilon-Thomas, Shari, Weber, Jeffrey, Hwu, Patrick, Radvanyi, Laszlo
Published 2013

12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

by Messina, Jane L., Fenstermacher, David A., Eschrich, Steven, Qu, Xiaotao, Berglund, Anders E., Lloyd, Mark C., Schell, Michael J., Sondak, Vernon K., Weber, Jeffrey S., Mulé, James J.
Published 2012

Therapeutic Vaccination for HPV Induced Cervical Cancers

by Brinkman, Joeli A., Hughes, Sarah H., Stone, Pamela, Caffrey, Angela S., Muderspach, Laila I., Roman, Lynda D., Weber, Jeffrey S., Kast, W. Martin
Published 2007

XL888 limits vemurafenib-induced proliferative skin events by suppressing paradoxical MAPK activation

by Phadke, Manali, Gibney, Geoffrey T., Rich, Carolyn J., Fedorenko, Inna V., Chen, Y. Ann, Kudchadkar, Ragini R., Sondak, Vernon K., Weber, Jeffrey, Messina, Jane L., Smalley, Keiran S. M.
Published 2015

Single-Walled Carbon Nanotubes Inhibit the Cytochrome P450 Enzyme, CYP3A4

by El-Sayed, Ramy, Bhattacharya, Kunal, Gu, Zonglin, Yang, Zaixing, Weber, Jeffrey K., Li, Hu, Leifer, Klaus, Zhao, Yichen, Toprak, Muhammet S., Zhou, Ruhong, Fadeel, Bengt
Published 2016

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma

by Sarnaik, Amod, Hall, MacLean, Mullinax, John, Royster, Erica, Richards, Allison, Crago, Georgina, Zager, Jonathan, Vernon, Sondak, Weber, Jeffrey, Pilon-Thomas, Shari
Published 2015

A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in pat...

by Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen
Published 2015